Abstract
We examined for microalbuminuria in patients with hepatitis B virus (HBV) infection, and the effect of antiviral treatment. Group I consisted of 38 patients who were inactive HbsAg carriers; group II included 21 HBeAg positive patients with chronic HBV infection who responded to antiviral treatment at 6 months; group III consisted of 24 patients with chronic HBV infection who did not respond to treatment at the end of 6 months; and group IV consisted of healthy controls. Initial level of microalbuminuria was significantly higher in group II compared to the levels measured at 3, 6, and 9 months (P<0.001). Although, there was a significant difference in microalbuminuria at initial and 3 months between group I and group II (P<0.001), no differences were found at 6 and 9 months. There was no significant difference betweeen group II and group III in terms of urine microalbuminuria at the beginning of the study, but statistically significant differences were determined at 3, 6, and 9 months (P<0.001). The measurement of microalbuminuria may indicate a preclinical renal damage, associated with chronic HBV infection. It may also be used to determine the response to treatment with interferon and lamivudine in children with HBV infection.
References
Yazigi N, Balisteri WF. Viral Hepatitis. In: Behrman RE, Kliegman RM, Jenson HB, Stanton BF. Eds. Nelson Texbook of Pediatrics, 18th edition. Philadelphia: JB Saunders, 2007. p. 1680–1690.
Pena A, Debora JM, Melgosa M, Picazo ML, Navarro M. Membranous nephropathy associated with hepatitis B in Spanish children. Clin Nephrol 2001; 55: 25–30.
Han SH. Extrahepatic manifestations of chronic hepatitis B. Clin Liver Dis 2004; 8: 403–418.
Baig S, Alamgir M. The extrahepatic manifestations of hepatitis B virus. J Coll Physicians Surg Pak 2008; 18: 451–457.
Wen L, Atkinson JP, Giclas PC. Clinical and laboratory evaluation of complemant deficinecy. J Allergy Clin Immunol 2004; 114: 677–687.
Marre M. Microalbuminurie. Signification and value. Presse Med 1993; 22: 1098–1103.
Vo Thi Diem H, Bourgois A, Bontems P, Goyens P, Buts JP, Nackers F, et al. Chronic hepatitis B infection: long term comparison of children receiving interferon alpha and untreated controls. J Pediatr Gastroenterol Nutr 2005; 40: 141–145.
Janssen HL, van Zonneveld M, Senturk H, Zeuzem S, Akarca US, Cakaloglu Y, et al. Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg positive chronic hepatitis B: a randomised trial. Lancet 2005; 365: 123–129.
Keeffe EB, Dieterich DT, Han SH, Jacobson IM, Martin P, Schiff ER, et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States. Clin Gastroenterol Hepatol 2004; 2: 87–106.
Akar A, Bournique B, Scholler R. Detection of hepatitis B virus DNA in serum by a nonisotopic hybridization technique. Clin Chem 1992; 38: 1352–1355.
Assadi FK. Quantitation of microalbuminuria using random urine samples. Pediatr Nephrol 2002; 17: 107–110.
Jones CA, Francis ME, Eberhardt MS, Chavers B, Coresh J, Engelgau M, et al. Microalbuminuria in the US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2002; 39: 445–159.
Lopez-Gonzalez MA, Lucas M, Mata F, Delgado F. Microalbuminuria as renal marker in recurrent acute tonsillitis and tonsillar hypertrophy in children. Int J Pediatr Otorhinolaryngol 1999; 50: 119–124.
Buzio C, Allegri L, Muti A, Perazzoli F, Bergamaschi E. Significance of albuminuria in the follow-up of acute poststreptococcal glomerulonephritis. Clin Nephrol 1994; 41: 259–264.
Ozdamar SO, Guncer S, Tinaztepe K. Hepatitis-B virus associated nephropathies: a clinicopathological study in 14 children. Pediatr Nephrol 2003; 18: 23–28.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kilic, M., Taskin, E., Sen, Y. et al. Microalbuminuria in chronic hepatitis B infection. Indian Pediatr 47, 511–515 (2010). https://doi.org/10.1007/s13312-010-0092-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13312-010-0092-4